Differences in gene expression and molecular pathway regulation between MYCN amplified and 2p gain neuroblastoma tumors
OBJECTIVE: The malignancy of neuroblastoma (NB) is strongly connected with MYCN oncogene status. The gene expression profile was investigated in three subtypes of NB related to MYCN status (amplification - MNA, 2p gain and normal) in order to identify new candidate genes and to elucidate development...
Main Author: | K. Szewczyk |
---|---|
Format: | Article |
Language: | English |
Published: |
Verduci Editore
2020-09-01
|
Series: | World Cancer Research Journal |
Subjects: | |
Online Access: | https://www.wcrj.net/wp-content/uploads/sites/5/2020/11/e1675.pdf |
Similar Items
-
Unfavorable Outcome of Neuroblastoma in Patients With 2p Gain
by: Katarzyna Szewczyk, et al.
Published: (2019-10-01) -
Implementation of the plasma MYCN/NAGK ratio to detect MYCN amplification in patients with neuroblastoma
by: Yan Su, et al.
Published: (2020-11-01) -
MYCN Amplification Is Associated with Reduced Expression of Genes Encoding γ-Secretase Complex and NOTCH Signaling Components in Neuroblastoma
by: Agarwal, P., et al.
Published: (2023) -
Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma
by: Haiwei Wang, et al.
Published: (2021-06-01) -
Droplet digital PCR as an alternative to FISH for MYCN amplification detection in human neuroblastoma FFPE samples
by: Dinesh Babu Somasundaram, et al.
Published: (2019-01-01)